Show simple item record

Phase II Randomized Preoperative Window-of-Opportunity Study of the PI3K Inhibitor Pictilisib Plus Anastrozole Compared With Anastrozole Alone in Patients With Estrogen Receptor-Positive Breast Cancer

dc.contributor.authorSchmid, Pen_US
dc.contributor.authorPinder, SEen_US
dc.contributor.authorWheatley, Den_US
dc.contributor.authorMacaskill, Jen_US
dc.contributor.authorZammit, Cen_US
dc.contributor.authorHu, Jen_US
dc.contributor.authorPrice, Ren_US
dc.contributor.authorBundred, Nen_US
dc.contributor.authorHadad, Sen_US
dc.contributor.authorShia, Aen_US
dc.contributor.authorSarker, S-Jen_US
dc.contributor.authorLim, Len_US
dc.contributor.authorGazinska, Pen_US
dc.contributor.authorWoodman, Nen_US
dc.contributor.authorKorbie, Den_US
dc.contributor.authorTrau, Men_US
dc.contributor.authorMainwaring, Pen_US
dc.contributor.authorGendreau, Sen_US
dc.contributor.authorLackner, MRen_US
dc.contributor.authorDerynck, Men_US
dc.contributor.authorWilson, TRen_US
dc.contributor.authorButler, Hen_US
dc.contributor.authorEarl, Gen_US
dc.contributor.authorParker, Pen_US
dc.contributor.authorPurushotham, Aen_US
dc.contributor.authorThompson, Aen_US
dc.date.accessioned2016-08-15T11:58:17Z
dc.date.available2015-12-14en_US
dc.date.issued2016-06-10en_US
dc.date.submitted2016-01-05T19:14:47.802Z
dc.identifier.issn0732-183Xen_US
dc.identifier.other10.1200/JCO.2015.63.9179
dc.identifier.urihttp://qmro.qmul.ac.uk/xmlui/handle/123456789/14490
dc.description.sponsorshipSupported by the National Institute for Health Research and Cancer Research UK funding (to Barts/Brighton Experimental Cancer Medicine Centre for the OPPORTUNE trial). Recruitment in the United Kingdom was supported by the National Institute for Health Research Cancer Research Network and the UK Experimental Cancer Medicine Centre network. Additional funding and study medication were provided by Genentech, South San Francisco, CA. Next-generation sequencing analysis was supported by Grant No. CG-12-07 from the National Breast Cancer Foundation of Australia (M.T.).en_US
dc.format.extent1987 - +en_US
dc.language.isoenen_US
dc.relation.ispartofJOURNAL OF CLINICAL ONCOLOGYen_US
dc.titlePhase II Randomized Preoperative Window-of-Opportunity Study of the PI3K Inhibitor Pictilisib Plus Anastrozole Compared With Anastrozole Alone in Patients With Estrogen Receptor-Positive Breast Canceren_US
dc.typeArticle
dc.rights.holder© 2016 by American Society of Clinical Oncology
dc.identifier.doi10.1200/JCO.2015.63.9179en_US
pubs.author-urlhttp://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000377378400006&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6aen_US
pubs.issue17en_US
pubs.notesNot knownen_US
pubs.publication-statusPublisheden_US
pubs.volume34en_US


Files in this item

Thumbnail
Name:
Revised manucript - OPPORTUNE - ...
Size:
1.087Mb
Format:
application/
Description:
Submitted version
View/Open

This item appears in the following Collection(s)

Show simple item record